Veru Inc. Terminates Material Definitive Agreement
Ticker: VERU · Form: 8-K · Filed: Sep 26, 2025 · CIK: 863894
Sentiment: neutral
Topics: material-definitive-agreement, termination, filing
TL;DR
VERU terminated a key deal, filing 8-K today.
AI Summary
Veru Inc. filed an 8-K on September 26, 2025, reporting the termination of a material definitive agreement as of September 22, 2025. The filing also includes financial statements and exhibits. The company, formerly known as The Female Health Co. and Wisconsin Pharmacal Company Inc., is based in Miami, Florida.
Why It Matters
The termination of a material definitive agreement could signal a shift in the company's strategic partnerships or operational plans, potentially impacting future revenue streams or development timelines.
Risk Assessment
Risk Level: medium — Termination of a material definitive agreement can indicate underlying issues with a partnership or contract, introducing uncertainty about the company's future business operations and financial performance.
Key Players & Entities
- VERU INC. (company) — Registrant
- The Female Health Co. (company) — Former company name
- Wisconsin Pharmacal Company Inc (company) — Former company name
- September 22, 2025 (date) — Date of earliest event reported
- September 26, 2025 (date) — Filing date
FAQ
What was the specific material definitive agreement that Veru Inc. terminated?
The filing does not specify the exact material definitive agreement that was terminated, only that such a termination occurred as of September 22, 2025.
When did Veru Inc. file this 8-K report?
Veru Inc. filed this 8-K report on September 26, 2025.
What is Veru Inc.'s principal executive office address?
Veru Inc.'s principal executive offices are located at 2916 N. Miami Avenue, Suite 1000, Miami, Florida 33127.
What are Veru Inc.'s former company names?
Veru Inc. was formerly known as The Female Health Co. and Wisconsin Pharmacal Company Inc.
What is the SIC code for Veru Inc.?
The Standard Industrial Classification (SIC) code for Veru Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on September 26, 2025 regarding VERU INC. (VERU).